We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-13.31%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$314B
AUM Growth
-$73.6B
Cap. Flow
-$17.9B
Cap. Flow %
-5.71%
Top 10 Hldgs %
13.83%
Holding
6,043
New
484
Increased
2,090
Reduced
2,254
Closed
848

Sector Composition

Rank Sector Weight
1 Technology 11.56%
2 Financials 9.82%
3 Healthcare 9.37%
4 Consumer Discretionary 7.85%
5 Energy 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XBIT icon
5026
XBiotech
XBIT
$68.3M
$51K ﹤0.01%
+10,036
New +$41.2K
HSTO
5027
DELISTED
Histogen Inc. Common Stock
HSTO
$51K ﹤0.01%
146
-533
-78% -$414K
MFAC.WS
5028
DELISTED
Megalith Financial Acquisition Corp. Warrants, each warrant exercisable for one share of Class A Com
MFAC.WS
$51K ﹤0.01%
+128,200
New +$62.7K
WRLSW
5029
DELISTED
Pensare Acquisition Corp. Warrant
WRLSW
$50K ﹤0.01%
+250,000
New +$98.6K
BBW icon
5030
Build-A-Bear
BBW
$435M
$49K ﹤0.01%
12,492
-46,163
-79% -$325K
GALT icon
5031
Galectin Therapeutics
GALT
$196M
$48K ﹤0.01%
14,068
-1,888
-12% -$9.02K
GPAQW
5032
DELISTED
Gordon Pointe Acquisition Corp. Warrant
GPAQW
$48K ﹤0.01%
+122,980
New +$61.3K
IOTS
5033
DELISTED
Adesto Technologies Corp
IOTS
$48K ﹤0.01%
+10,916
New +$52.1K
FRED
5034
DELISTED
Fred's Inc
FRED
$48K ﹤0.01%
25,510
-118,818
-82% -$308K
SPAQ.WS
5035
DELISTED
Spartan Energy Acquisition Corp. Warrants, each whole warrant exercisable for one Class A common sto
SPAQ.WS
$47K ﹤0.01%
+48,333
New +$63.1K
CELH icon
5036
Celsius Holdings
CELH
$7.42B
$46K ﹤0.01%
+39,642
New +$49.9K
SIOX
5037
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$46K ﹤0.01%
5,787
-15,357
-73% -$221K
TIBRW
5038
DELISTED
Tiberius Acquisition Corporation Warrant
TIBRW
$46K ﹤0.01%
+117,500
New +$58K
KBLMW
5039
DELISTED
KBL Merger Corp. IV Warrant
KBLMW
$45K ﹤0.01%
+500,000
New +$79.6K
LINC icon
5040
Lincoln Educational Services
LINC
$1.33B
$44K ﹤0.01%
+13,847
New +$32.7K
VHC icon
5041
VirnetX Holding Corp
VHC
$54.6M
$44K ﹤0.01%
+910
New +$61.7K
NFC.WS
5042
DELISTED
New Frontier Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at
NFC.WS
$44K ﹤0.01%
+50,000
New +$53.4K
FPAC.WS
5043
DELISTED
Far Point Acquisition Corporation Warrants, exercisable for one share of Class A Common Stock for $1
FPAC.WS
$43K ﹤0.01%
+33,333
New +$50.3K
HOS
5044
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$42K ﹤0.01%
28,795
+968
+3% +$3.39K
AVDL
5045
DELISTED
Avadel Pharmaceuticals
AVDL
$41K ﹤0.01%
16,000
-4,877
-23% -$16.6K
PTN
5046
Palatin Technologies
PTN
$13.5M
$40K ﹤0.01%
45
-31
-41% -$32.3K
GRPN icon
5047
PUT
Groupon
GRPN
$1.04B
$39K ﹤0.01%
610
SNNA
5048
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$39K ﹤0.01%
16,700
-7,335
-31% -$64.7K
OVID icon
5049
Ovid Therapeutics
OVID
$420M
$38K ﹤0.01%
15,630
-11,329
-42% -$51.7K
LUMO
5050
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$37K ﹤0.01%
2,681
-6,209
-70% -$109K

Similar funds

Goldman Sachs's Q4 2018 Portfolio in Review

As of Q4 2018, Goldman Sachs held 6,043 positions worth $314B, down 19% from $387B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Goldman Sachs withdrew a net $17.9B in Q4 2018, closing 848 positions and reducing 2,254 holdings. Its most notable exit was Energy Transfer Partners, L.P., an estimated $1.64B position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Goldman Sachs opened a new position in Linde worth $335M.

  • Goldman Sachs's largest Q4 2018 buy was Linde: 2,149,240 shares worth $335M.
  • Goldman Sachs added most to Energy Transfer Partners in Q4 2018, an estimated $1.35B increase.
  • Goldman Sachs's biggest Q4 2018 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $719M.
  • Goldman Sachs fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.64B.
  • Goldman Sachs's ten largest holdings make up 14% of its $314B portfolio in Q4 2018.
  • Goldman Sachs opened 484 new positions and closed 848 in Q4 2018.
  • Goldman Sachs's portfolio value fell 19% quarter-over-quarter to $314B.

Based on Goldman Sachs's 13F filing for Q4 2018, filed 14 Feb 2019.